SCHEMBL6313240

SCHEMBL6313240

CN(C)/C=N\C(=O)/C=C/c1ccccc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GLA P06280 1/20 0.52
▸ TDP1 Q9NUW8 1/20 0.52
▸ MAPT P10636 4/20 0.50
▸ SMN1; SMN2 Q16637 3/20 0.50
▸ LMNA P02545 3/20 0.50
▸ HDAC3 O15379 2/20 0.50
▸ HDAC4 P56524 2/20 0.50
▸ HDAC1 Q13547 2/20 0.50
▸ HDAC2 Q92769 2/20 0.50
▸ HDAC8 Q9BY41 2/20 0.50
▸ HDAC6 Q9UBN7 2/20 0.50
▸ PLIN1 O60240 2/20 0.50
▸ RECQL P46063 2/20 0.50
▸ PLIN5 Q00G26 2/20 0.50
▸ ABHD5 Q8WTS1 2/20 0.50
▸ TNKS O95271 1/20 0.50
▸ HCAR2 Q8TDS4 1/20 0.50
▸ HDAC7 Q8WUI4 1/20 0.50
▸ HDAC10 Q969S8 1/20 0.50
▸ HDAC11 Q96DB2 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6313245 1.00 GLA (0.52) GLATDP1MAPTSMN1; SMN2LMNA
SCHEMBL6312381 0.79 NPC1 (0.47) GLATDP1MAPTSMN1; SMN2LMNA
SCHEMBL27560284 0.78 MAPT (0.57) GLATDP1MAPTSMN1; SMN2LMNA
SCHEMBL11476908 0.76 TDP1 (0.61) GLATDP1MAPTSMN1; SMN2LMNA
SCHEMBL11476916 0.76 TDP1 (0.61) GLATDP1MAPTSMN1; SMN2LMNA
SCHEMBL4029202 0.75 MAPT (0.64) GLATDP1MAPTSMN1; SMN2LMNA
SCHEMBL4023735 0.75 MAPT (0.64) GLATDP1MAPTSMN1; SMN2LMNA
SCHEMBL6313480 0.75 MAPT (0.53) GLATDP1MAPTSMN1; SMN2LMNA
SCHEMBL6313483 0.75 MAPT (0.53) GLATDP1MAPTSMN1; SMN2LMNA
SCHEMBL6320059 0.75 TDP1 (0.55) GLATDP1MAPTSMN1; SMN2LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6956049-B1 Methods of modulating processes mediated by excitatory amino acid receptors MERCK & CO., INC. (US) 2005-10-18 — — US disclosed
EP-1214303-A1 HETEROCYCLIC COMPOUNDS AND METHODS OF USE THEREOF Merck & Co., Inc. (US) 2002-06-19 — — EP disclosed
WO-2001016121-A1 HETEROCYCLIC COMPOUNDS AND METHODS OF USE THEREOF MERCK & CO., INC. (US) 2001-03-08 — — WO disclosed
Send feedback